TCL Archive Senate Report Calls For Review Of Progress In Cancer Program Restores Prevention And Control Funding September 18, 1992
TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity October 9, 2009
TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007